Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Tomomi, Manako"'
Autor:
Noritaka Komune, Kuniaki Sato, Mayumi Ono, Akira Imaizumi, Shogo Masuda, Shinsaku Itoyama, Tomomi Manako, Ryosuke Kuga, Takahiro Hongo, Ryunosuke Kogo, Hideya Onishi, Takashi Nakagawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Squamous cell carcinoma of the external auditory canal (EACSCC) is an extraordinarily rare and aggressive malignant disease. Establishment of EACSCC cell line with robust molecular characteristics is essential for the basic and translational
Externí odkaz:
https://doaj.org/article/f96588624d934622a39d349174d71508
Autor:
Takahiro WakasakiI, Tomomi Manako, Ryuji YasumatsuI, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda, Moriyasu YamauchiID, Yuichiro Kuratomi, Emi Nishimura, Toranoshin Takeuchi, Mioko Matsuo, Rina Jiromaru, Kazuki Hashimoto, Noritaka Komune, Takashi Nakagawa
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303720 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0271907.].
Externí odkaz:
https://doaj.org/article/a5774a3734e14634a6aa219cde19e5ff
Autor:
Ryunosuke Kogo, Tomomi Manako, Takeshi Iwaya, Satoshi Nishizuka, Hayato Hiraki, Yasushi Sasaki, Masashi Idogawa, Takashi Tokino, Ayaka Koide, Noritaka Komune, Ryuji Yasumatsu, Takashi Nakagawa
Publikováno v:
Cancer Medicine, Vol 11, Iss 21, Pp 3960-3968 (2022)
Abstract There is no useful biomarker to evaluate treatment response and early relapse in head and neck squamous cell carcinoma (HNSCC). Circulating tumor DNA (ctDNA) is a promising biomarker for detecting minimal residual diseases and monitoring tre
Externí odkaz:
https://doaj.org/article/ae54eb39620e45b89bdbf0cace90eabc
Autor:
MIOKO MATSUO, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, MASANOBU SATO, TOMOMI MANAKO, TAKASHI NAKAGAWA
Publikováno v:
Cancer Diagnosis & Prognosis; Sep/Oct2024, Vol. 4 Issue 5, p658-666, 9p
Autor:
Takahiro Wakasaki, Tomomi Manako, Ryuji Yasumatsu, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda, Moriyasu Yamauchi, Yuichiro Kuratomi, Emi Nishimura, Toranoshin Takeuchi, Mioko Matsuo, Rina Jiromaru, Kazuki Hashimoto, Noritaka Komune, Takashi Nakagawa
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0271907 (2022)
ObjectivesThe benefit of sequential therapy after immune checkpoint inhibitor (ICI) treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) has been recently reported. Furthermore, there is a growing interest in the im
Externí odkaz:
https://doaj.org/article/6b838054b0db431388ae8c3d7133aafb
Autor:
Mioko, Matsuo, Shingo, Baba, Kazuki, Hashimoto, Takuro, Isoda, Yoshiyuki, Kitamura, Ryunosuke, Kogo, Rina, Jiromaru, Takahiro, Hongo, Tomomi, Manako, Takashi, Nakagawa
Publikováno v:
Anticancer Research. 43:183-190
Differentiated thyroid cancer (DTC) has a good prognosis, except in the case of patients with radioiodine therapy (RIT)-refractory cancer. However, since DTC is essentially a slowly progressing cancer, it is usually judged to be a DTC with a poor pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1941d53de7610dae31e979029e516bc0
https://doi.org/10.21873/anticanres.16148
https://doi.org/10.21873/anticanres.16148
Autor:
TOMOMI MANAKO, RYUJI YASUMATSU, TAKAFUMI NAKANO, MIOKO MATSUO, TORANOSHIN TAKEUCHI, MASAHIKO TAURA, AKIHIRO TAMAE, MORIYASU YAMAUCHI, MUNEYUKI MASUDA, KENICHI TAGUCHI, TAKASHI NAKAGAWA
Publikováno v:
In Vivo
Background/Aim: The advent of immune checkpoint inhibitor (ICI) treatment has transformed the treatment of recurrent or metastatic head and neck cancer; however, nasopharyngeal carcinoma (NPC) has not been included in major phase III trials. The clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96cbc979f4b51e1621ef859ba277816d
https://europepmc.org/articles/PMC10026669/
https://europepmc.org/articles/PMC10026669/
Autor:
MIOKO MATSUO, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, MASAHIKO TAURA, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO, TAKASHI NAKAGAWA
Publikováno v:
In Vivo; Sep/Oct2023, Vol. 37 Issue 5, p2188-2196, 9p
Autor:
MIOKO MATSUO, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO, TAKASHI NAKAGAWA
Publikováno v:
In Vivo; Sep/Oct2023, Vol. 37 Issue 5, p2147-2154, 8p
Autor:
KAZUKI HASHIMOTO, RYUJI YASUMATSU, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, HIDEOKI URYU, TORAHIKO NAKASHIMA, AKIHIRO TAMAE, RISA TANAKA, MASAHIKO TAURA, TORANOSHIN TAKEUCHI, TAKAMASA YOSHIDA, TAKASHI NAKAGAWA
Publikováno v:
Anticancer Research. 42:981-989
The efficacy of programmed cell death 1 (PD-1) inhibitor therapy for patients with recurrent and/or metastatic salivary gland carcinoma (R/M SGC) remains unclear.We retrospectively analyzed 36 patients with R/M SGC treated with PD-1 inhibitor. The ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ce91ee1435e83df62c4b135e150ac7
https://doi.org/10.21873/anticanres.15558
https://doi.org/10.21873/anticanres.15558